跳至主要内容
临床试验/NL-OMON53168
NL-OMON53168已完成不适用

A Prospective and Consecutive Clinical Evaluation of Soft Tissue Regeneration*s L-C Ligament® in Primary ACL Reconstruction - L-C Ligament

Biorez, Inc.0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18 to 45 years of age.
  • Males and females.
  • If female, for the 24 months post-operative, actively practicing a
  • contraception method, or surgically sterilised or
  • postmenopausal.
  • Acute unilateral ACL tear, or partial or complete tear of the ACL
  • that occurred within 91 days (13 weeks) of injury, and requires
  • reconstruction of the ACL.
  • Passive flexion - 120° and passive extension on the target knee
  • is the same as the contralateral knee.
  • Patients with all types of lateral and/or medial meniscal tears
  • which are repairable.
  • Medial Collateral Ligament (MCL) grade 2 or less.
  • Potential Subject is able to provide informed consent and must
  • sign the EC-approved Informed Consent Form
  • Must be physically and mentally willing and able to comply with
  • post-operative rehabilitation and routinely scheduled clinical,
  • radiographic and rehabilitation follow up visits through 24

排除标准

  • Prior ACL reconstruction or other surgical procedure on the
  • affected (target) knee.
  • Chronic ACL injury; interventional surgery scheduled 92 days or
  • more after ACL injury.
  • Professional athletes currently engaged in active sport
  • Prior fracture of the affected (target) leg
  • Previous or current ACL injury on contra-lateral leg.
  • Multi-ligament reconstruction.
  • Malalignment with varus thrust
  • Patient > 193 cm tall (6* 4*).
  • The patient does not follow pre-operative rehabilitation.
  • Confirmed connective tissue disorder.
  • Signs of moderate to severe degenerative joint disease
  • (Osteoarthritis)
  • Concomitant injuries to the knee or lower extremities requiring
  • treatment, per surgeon's discretion.
  • Severe pain, swelling, or redness within 24 hours prior to
  • Complete or partial Post Cruciate Ligament (PCL) tear.
  • Any of the following: 1/3rd meniscal resection; complex doublebucket
  • tear; partially repaired meniscal tears.
  • Patient requires treatment of articular cartilage on target leg
  • The patient is mentally compromised.
  • The patient has a neuromuscular disorder that would engender
  • unacceptable risk of knee instability, prosthesis fixation failure,
  • or complications in postoperative care.
  • The patient has a diagnosed systemic disease that would affect
  • his/her safety or the study outcome.
  • The patient has an active or latent infection in or about the
  • affected knee joint or an infection site distant from the knee that
  • may spread to the knee hematogenously.
  • Pregnant based on a positive beta hCG serum or an in vitro
  • diagnostic test result or breast-feeding.
  • The patient is obese with a BMI ³ 35.
  • The patient has a known allergy to PLLA.
  • The patient has a medical condition or comorbidity that would
  • interfere with study participation.

研究者

发起方
Biorez, Inc.

相似试验

A Prospective and Consecutive Clinical Evaluation of... | 临床试验